Pacira Pharmaceuticals (PCRX)

28.85 +0.41  +1.44%  May 21, 5:00PM
Add to Watchlists Create an Alert

Pacira Pharmaceuticals Cash from Investing TTM:

-29.52M for Dec. 31, 2012
View Full Chart

Pacira Pharmaceuticals Cash from Investing TTM Chart

    Pacira Pharmaceuticals Historical Cash from Investing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -29.52M
    Sept. 30, 2012 -63.65M
    June 30, 2012 -64.40M
    March 31, 2012 -37.82M
    Dec. 31, 2011 -36.12M
       
    Sept. 30, 2011 -27.30M
    June 30, 2011 -26.64M
    March 31, 2011 -7.184M
    Dec. 31, 2010 -6.769M

    About Cash From Investing (TTM)

    Definition: Cash from Investing

    Learn More

    Get data for

    PCRX Cash from Investing TTM Benchmarks

    Companies
    BioScrip 93.88M
    Neurocrine Biosciences -24.62M
    Lannett Company -8.131M

    PCRX Cash from Investing TTM Rankings

    Overall 67th percentile
    2619 of 8002
    Sector 38th percentile
    422 of 684 in Healthcare
    Industry 42nd percentile
    31 of 54 in Drug Manufacturers - Major

    PCRX Cash from Investing TTM Range, Past 5 Years

    Minimum -64.41M Jun 2012
    Maximum -6.769M Dec 2010
    Average -33.27M